In Search of the Optimal Depth for Self-Expandable Valves

Despite the use of the different imaging approaches to calculating implantation depth, optimal depth is reached only 30% of the time. Multiple imaging does not offer a uniform perspective and therefore influence reporting. 

prótesis autoexpandibles

Basically, we do not have a clear idea of what constitutes optimal depth on a case by case basis and, what is worse, even though we knew the exact point, there is little chance of reaching accurate implantation depth. 

Clinical and hemodynamic outcomes of 258 patients undergoing TAVR with third generation self-expandable valves were analyzed as to their approach to optimal depth calculation: arithmetic mean, the arithmetic mean of the measured distances from the noncoronary cusp and the left coronary cusp to the distal prosthesis end; noncoronary cusp distance, the distance from the noncoronary cusp to the distal prosthesis end, and the deepest edge of the distal prosthesis end, among others.

Regardless the approach, exact implantation depth was achieved in less than 30% of cases. 


Read also: Valve-in-Valve with Self-Expanding Prosthesis: What Happens with Gradients at One Year?


The deepest edge method is the most precise to differentiate a few relevant outcome parameters, such as the need for permanent pacemaker implantation. 

The hemodynamic outcomes were not affected, regardless success. 

Conclusion

Optimal implantation depth could only be achieved in less than 30% of patients, regardless the approach used to calculate it. In addition, the different approaches do not offer a uniform perspective to calculate the exact implantation depth. 

 

Original title: Navigating the “Optimal Implantation Depth” With a Self-Expandable TAVR Device in Daily Clinical Practice.

Reference: Kerstin Piayda et al. J Am Coll Cardiol Intv 2020, article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

T-TEER: Beyond Traditional Pulmonary Hypertension Thresholds

Significant tricuspid regurgitation (TR) is associated with progressive functional deterioration, heart failure (HF) hospitalizations, and increased mortality. In recent years, transcatheter tricuspid edge-to-edge repair...

Is left atrial appendage closure safe in patients with reduced ejection fraction?

Patients with heart failure with reduced ejection fraction (HFrEF) were excluded from the major randomized trials evaluating percutaneous left atrial appendage closure (LAAC), and...

Left Atrial Appendage Closure in Spain: Sustained Growth and Favorable Real-World Outcomes

Oral anticoagulation remains the standard treatment for stroke prevention in patients with atrial fibrillation. However, many patients have a high bleeding risk or contraindications...

HERA-TAVI: Intra-Annular vs Supra-Annular Valves in TAVI

The HERA-TAVI study is an international multicenter registry that compared the clinical and hemodynamic outcomes of contemporary self-expanding transcatheter heart valves with intra-annular (IA)...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

T-TEER: Beyond Traditional Pulmonary Hypertension Thresholds

Significant tricuspid regurgitation (TR) is associated with progressive functional deterioration, heart failure (HF) hospitalizations, and increased mortality. In recent years, transcatheter tricuspid edge-to-edge repair...

Is left atrial appendage closure safe in patients with reduced ejection fraction?

Patients with heart failure with reduced ejection fraction (HFrEF) were excluded from the major randomized trials evaluating percutaneous left atrial appendage closure (LAAC), and...

Left Atrial Appendage Closure in Spain: Sustained Growth and Favorable Real-World Outcomes

Oral anticoagulation remains the standard treatment for stroke prevention in patients with atrial fibrillation. However, many patients have a high bleeding risk or contraindications...